Vellenga E - Search Results

1

Breakpoint analysis by fluorescence in situ hybridization in myelodysplastic syndromes with t(3;12)(q26;p13) and expression of EVI1.

van de Loosdrecht AA, Kok K, de Vries B, van der Veen AY, van den Berg E, Esselink MT, Marynen P, Vellenga E, van Imhoff GW. van de Loosdrecht AA, et al. Among authors: vellenga e. Leukemia. 2000 Oct;14(10):1857-8. doi: 10.1038/sj.leu.2401895. Leukemia. 2000. PMID: 11021761 No abstract available.

2

Mitochondrial disruption and limited apoptosis of erythroblasts are associated with high risk myelodysplasia. An ultrastructural analysis.

van de Loosdrecht AA, Brada SJ, Blom NR, Hendriks DW, Smit JW, van den Berg E, de Wolf JT, Vellenga E. van de Loosdrecht AA, et al. Among authors: vellenga e. Leuk Res. 2001 May;25(5):385-93. doi: 10.1016/s0145-2126(00)00151-x. Leuk Res. 2001. PMID: 11301106

3

Limited numbers of apoptotic cells in fresh paraffin embedded bone marrow samples of patients with myelodysplastic syndrome.

Brada SJ, van de Loosdrecht AA, Koudstaal J, de Wolf JT, Vellenga E. Brada SJ, et al. Among authors: vellenga e. Leuk Res. 2004 Sep;28(9):921-5. doi: 10.1016/j.leukres.2004.01.001. Leuk Res. 2004. PMID: 15234568

4

The spontaneous expression of interleukin-1 beta and interleukin-6 is associated with spontaneous expression of AP-1 and NF-kappa B transcription factor in acute myeloblastic leukemia cells.

Dokter WH, Tuyt L, Sierdsema SJ, Esselink MT, Vellenga E. Dokter WH, et al. Among authors: vellenga e. Leukemia. 1995 Mar;9(3):425-32. Leukemia. 1995. PMID: 7885041

5

Interleukin-4-mediated inhibition of C-Fos mRNA expression: role of the lipoxygenase directed pathway.

Dokter WH, Sierdsema SJ, Esselink MT, Halie MR, Vellenga E. Dokter WH, et al. Among authors: vellenga e. Leukemia. 1994 Jul;8(7):1181-4. Leukemia. 1994. PMID: 8035610

6

Myelodysplasia and apoptosis: new insights into ineffective erythropoiesis.

van de Loosdrecht AA, Vellenga E. van de Loosdrecht AA, et al. Among authors: vellenga e. Med Oncol. 2000 Feb;17(1):16-21. doi: 10.1007/BF02826211. Med Oncol. 2000. PMID: 10713655 Review. No abstract available.

7

A dual function for p38 MAP kinase in hematopoietic cells: involvement in apoptosis and cell activation.

Birkenkamp KU, Dokter WH, Esselink MT, Jonk LJ, Kruijer W, Vellenga E. Birkenkamp KU, et al. Among authors: vellenga e. Leukemia. 1999 Jul;13(7):1037-45. doi: 10.1038/sj.leu.2401447. Leukemia. 1999. PMID: 10400419

8

Central diabetes insipidus preceding acute myeloid leukemia with t(3;12)(q26;p12).

Nieboer P, Vellenga E, Adriaanse R, van de Loosdrecht AA. Nieboer P, et al. Among authors: vellenga e. Neth J Med. 2000 Feb;56(2):45-7. doi: 10.1016/s0300-2977(99)00110-2. Neth J Med. 2000. PMID: 10710939

9

The effects of IL-1 beta and IL-4 on the proliferation and endogenous secretion of growth factors by acute myeloblastic leukemic cells.

Wagteveld AJ, Esselink MT, Limburg P, Halie MR, Vellenga E. Wagteveld AJ, et al. Among authors: vellenga e. Leukemia. 1992 Oct;6(10):1020-4. Leukemia. 1992. PMID: 1405754

10

Expression and regulation of IL-4 receptors on human monocytes and acute myeloblastic leukemic cells.

Wagteveld AJ, van Zanten AK, Esselink MT, Halie MR, Vellenga E. Wagteveld AJ, et al. Among authors: vellenga e. Leukemia. 1991 Sep;5(9):782-8. Leukemia. 1991. PMID: 1943230

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

498 results

Search Page

Filters